Genworth Financial’s Arcellx ACLX Stock Holding History

Genworth Financial’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,791	Closed	-$56.6K	–	3
2023 Q2	$56.6K	Buy	+1,791	New	+$68.5K	0.02%	4

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Genworth Financial's ACLX Position: Q3 2023 in Review

Genworth Financial sold out of Arcellx (ACLX) in Q3 2023, closing a stake of 1,791 shares — an estimated $56.6K sold.

Genworth Financial first reported a position in ACLX in Q2 2023 and held it in 1 quarter. The position peaked at $56.6K in Q2 2023. 136 funds tracked by Wall St. Rank hold ACLX as of Q3 2023.

Genworth Financial reported no remaining Arcellx position as of Q3 2023 after selling out during the quarter.
Genworth Financial sold 1,791 Arcellx shares in Q3 2023, an estimated $56.6K.
Genworth Financial first reported a position in Arcellx in Q2 2023 and held it in 1 quarter.
Genworth Financial's Arcellx position peaked at $56.6K in Q2 2023.
136 funds tracked by Wall St. Rank held Arcellx as of Q3 2023.

Based on Genworth Financial's 13F filing for Q3 2023, filed 25 Oct 2023.